abstract |
The invention relates to derivatives of azetidine and cyclobutane, as well as compositions containing these compounds, their uses and methods of preparation which are JAK inhibitors useful in the treatment of JAK-related diseases, including, for example, inflammatory and autoimmune disorders, as well as cancer. |